New test for germs in diabetic foot bone infections
Part of Heart & circulation, Hormones & metabolism, Infections, Skin clinical trials.
This study tests a new device that quickly identifies the germs in foot wounds of people with diabetes and bone infections. It may help doctors choose the right antibiotic faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes.
- You have a foot wound with a bone infection (osteomyelitis).
- You are willing to have a small sample taken from the wound for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new device that measures blood sugar without a finger prick. It is open to healthy adults and people with type 2 diabetes, to see if the non-invasive meter works as well as standard blood tests.
This study aims to find out which bacteria are causing your diabetic foot infection by testing a small sample from your wound. This could help doctors choose better treatments for you and others with similar infections.
This trial is testing a new way to take a small sample of infected bone from the foot of people with diabetes. It aims to see if a bedside biopsy is safe and accurate for diagnosing bone infection, so you may avoid more invasive procedures.
This study uses a special imaging scan (PET/CT) to see if a foot infection has spread to the bone in people with diabetes. The scan may help doctors diagnose bone infection more accurately, potentially avoiding unnecessary treatments.
This study is testing a new way to check blood flow in the feet of people with diabetes who have foot ulcers. The goal is to find out if this test can help doctors diagnose blocked arteries more accurately, which could guide better treatment.
This study is testing a device called Feetsee that helps monitor foot health in people with diabetes. It might help catch foot problems early, so you can avoid serious issues.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.